All the information you need about CleveXel Pharma to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2022-09-02 | Partially confidential | 2021-12-31 | Complete |
| 2021-09-13 | Partially confidential | 2020-12-31 | Complete |
| 2018-07-18 | Partially confidential | 2017-12-31 | Complete |
| 2017-07-18 | Public | 2016-12-31 | Complete |
| Name | CLEVEXEL PHARMA |
| Siren | 790115026 |
| Closing | 2021-12-31 |
| Registry code | 7501 |
| Registration number | 153193 |
| Management number | 2017B19347 |
| Activity code | 7219Z |
| Closing date n-1 | 2020-12-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 12 |
| Filing date | 2022-09-02 |
| Modification | 00 Annual accounts entered without anomaly |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Partially confidential |
| Address | 75013 PARIS |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
AF Concessions, Patents and Similar Rights | 400.00 | 400.00 | 400.00 | |
AH Goodwill | 1.00 | 1.00 | 1.00 | |
AT Other tangible assets | 2 914.00 | 1 901.00 | 1 013.00 | 2 914.00 |
BH Other financial assets | 103.00 | 103.00 | 103.00 | |
BJ TOTAL (I) | 254 047.00 | 2 301.00 | 251 746.00 | 254 047.00 |
BX Customers and related accounts | 382 558.00 | 382 558.00 | 382 558.00 | |
BZ Other receivables | 284 726.00 | 284 726.00 | 284 726.00 | |
CF Cash and cash equivalents | 184 826.00 | 184 826.00 | 184 826.00 | |
CH Prepaid expenses | 294.00 | 294.00 | 294.00 | |
CJ TOTAL (II) | 852 403.00 | 852 403.00 | 852 403.00 | |
CO Grand total (0 to V) | 1 106 450.00 | 2 301.00 | 1 104 149.00 | 1 106 450.00 |
CU Other investments | 250 629.00 | 250 629.00 | 250 629.00 | |
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 1 883 484.00 | 1 883 484.00 | 1 883 484.00 | |
DB Share, merger, contribution premiums, etc. | 311 642.00 | 311 642.00 | 311 642.00 | |
DD Legal reserve (1) | 128 030.00 | 128 030.00 | 128 030.00 | |
DF Regulated reserves (1) | 28 078.00 | 28 078.00 | 28 078.00 | |
DG Other reserves | 2 502 463.00 | 2 502 463.00 | 2 502 463.00 | |
DH Retained earnings | -6 250 936.00 | -6 604 910.00 | -6 250 936.00 | |
DI RESULTS FOR THE YEAR (Profit or Loss) | -224 464.00 | 353 975.00 | -224 464.00 | |
DL TOTAL (I) | -1 621 702.00 | -1 397 238.00 | -1 621 702.00 | |
DN Conditional advances | 17 355.00 | 18 915.00 | 17 355.00 | |
DO TOTAL (II) | 17 355.00 | 18 915.00 | 17 355.00 | |
DV Miscellaneous Loans and Financial Debts (4) | 395 000.00 | 200 000.00 | 395 000.00 | |
DX Trade payables and related accounts | 497 665.00 | 419 954.00 | 497 665.00 | |
DY Tax and social security liabilities | 710 688.00 | 807 116.00 | 710 688.00 | |
EA Other liabilities | 1 105 142.00 | 1 204 481.00 | 1 105 142.00 | |
EC TOTAL (IV) | 2 708 496.00 | 2 631 551.00 | 2 708 496.00 | |
EE Grand total (I to V) | 1 104 149.00 | 1 253 228.00 | 1 104 149.00 | |
EG Accrued income and payables due within one year | 2 708 496.00 | 2 631 551.00 | 2 708 496.00 | |
